Glycosylation Profiling of α/β T Cell Receptor Constant Domains Expressed in Mammalian Cells

Kai Zhang1, Stephen J Demarest2, Xiufeng Wu2

  • 1Eli Lilly Biotechnology Center, 10300 Campus Point Drive, San Diego, CA, 92121, USA. zhangkai@lilly.com.

Insights

This study details a mass spectrometry method for analyzing N-linked glycans on recombinant T cell receptors (TCRs) produced in mammalian cells. The protocol characterizes glycosylation site occupancy and heterogeneity for therapeutic protein development.

Area of Science:

  • Biochemistry
  • Proteomics
  • Glycoscience

Background:

  • Glycosylation of recombinant proteins is crucial for their biological function and interaction with receptors.
  • Recombinant T cell receptors (TCRs) show therapeutic potential but require thorough characterization.
  • Mammalian cell expression systems are commonly used for producing complex recombinant glycoproteins.

Purpose of the Study:

  • To develop and present a mass spectrometry-based protocol for detailed glycosylation analysis of recombinant fusion proteins containing TCR domains.
  • To characterize N-linked glycosylation, including site occupancy and glycan heterogeneity.
  • To provide a method for understanding the structural and compositional aspects of glycans on therapeutic TCR candidates.

Main Methods:

  • A "bottom up" mass spectrometry approach was employed for glycan profiling.
  • Peptide mass mapping was utilized to identify glycosylation sites.
  • Mass spectrometry was used to analyze glycan heterogeneity and composition.

Main Results:

  • The protocol successfully characterized N-linked glycosylation in recombinant fusion proteins with TCR domains.
  • Detailed analysis of glycan site occupancy and heterogeneity was achieved.
  • The method provides insights into potential glycan structures present on the recombinant proteins.

Conclusions:

  • The presented mass spectrometry protocol offers a robust method for comprehensive glycoprofiling of recombinant TCRs.
  • This characterization is essential for advancing the development of TCR-based therapeutics.
  • Understanding glycosylation is key to predicting in vivo behavior and efficacy of glycoprotein therapeutics.